• Renowned, experienced industry leader in newly created role for Cytiva
• Ruffieux joins Cytiva executive team on 1 July 2024

Cytiva is strengthening its leadership team with one of the biotechnology industry’s most highly regarded and experienced leaders, Pierre-Alain Ruffieux, who will join as Chief Operating Officer.

Ruffieux will come onboard 1 July. He will be responsible for orchestrating Cytiva’s global operations and supply chain, which processes an average of 30 000 orders per month, providing customers with critical technologies and services across more than 80 countries.

Pierre-Alain Ruffieux says: "I am honored to join Cytiva in this role. The company mission resonates deeply with my personal passion for innovation and operational excellence. As a former customer, I've always admired the exceptional quality and reliability of Cytiva’s products and services. Leveraging this firsthand experience and working closely with Cytiva’s talented team, I look forward to further enhancing our customer experience and fostering sustainable global growth.”

Chris Riley, Cytiva CEO and Danaher Executive Vice President, says: “We’re excited for what Pierre-Alain will bring to our customers with his depth of experience, expertise, and customer perspective. He has a proven track record from serving as CEO of Lonza, one of our largest customers, as well as Head of Global Pharma Technical Operations at Roche, where he oversaw pharmaceutical commercial manufacturing and supply chain operations. I look forward to working with him to sharpen Cytiva’s ability to deliver with quality and on time to our customers and their patients.”